Personal stories

It was a shocking diagnosis for the Dallas infant, who was just 2 months old when he contracted the disease. For Child Health Day his mom shares the incredible journey he’s been on as a patient—and pint-sized advocate.

Johnson & Johnson’s Chief Human Resources Officer reveals how the organization stays forward-thinking after 133 years in business, garnering it a spot on Fast Company‘s inaugural Best Workplaces for Innovators list.

Hear from those living with HIV. Learn how Johnson & Johnson is working to #makeHIVhistory.

Johnson & Johnson’s Chief Human Resources Officer reflects on a life-changing trip he took to Dhaka with the organization—and announces a new $5 million pledge to Save the Children’s Centennial Commitment.

Malaria. Newborn jaundice. Hearing loss. These are just some of the health problems that the winners of this year’s Johnson & Johnson Africa Innovation Challenge are tackling by leveraging everything from apps to a smart formula for soap.

Our Chief Historian celebrates Edith Von Kuster’s groundbreaking role and how it set the tone for company culture in the century-plus to come.

It seems pretty simple: curly or straight, fine or thick, right? There’s actually a lot more to your kid’s locks, and understanding the science behind your little one’s unique hair type can help make a big difference when it comes to cleaning and styling. Take this fun quiz to test your smarts.

Despite being one of the oldest viruses known to infect man, there’s been slow progress toward a cure for the disease. But a promising clinical trial, led by Janssen researcher Heather Davis, Ph.D., is sparking hope.

As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

Announced ahead of the International AIDS Society Conference on HIV Science in Mexico City, the new study will evaluate an investigational vaccine regimen in eight countries around the world for its ability to protect people from HIV infection.